Follow the 에이프릴바이오 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 에이프릴바이오 has logged 46 reports. Market capitalisation: €421.6bn. The latest transaction was reported on 1 July 2026 (Sale). Among the most active insiders: 유한양행. Every trade is accessible without an account.
40
Insider Decl.
n/a
Thresholds
n/a
20 ops.
Buy Volume
n/a
13 ops.
Sell Volume
Fundamental score
Ranked 18,052 of 29,064 companies
44.5
score / 100
Value
30
Quality
59
FCF yld-0.9%
Earn yld-2.3%
EV/EBITDA·
ROE-11%
Gross mgn100%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.